Allarity Therapeutics, Inc. (ALLR)
(Delayed Data from NSDQ)
$1.00 USD
-0.23 (-18.70%)
Updated May 3, 2024 04:00 PM ET
After-Market: $1.00 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value B Growth A Momentum D VGM
Cash flow Statements
Fiscal Year End for Allarity Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -11.90 | -16.06 | -26.65 | -6.62 | NA |
Depreciation/Amortization & Depletion | 0.04 | 17.63 | 0.11 | 0.05 | NA |
Net Change from Assets/Liabilities | 3.35 | -0.33 | 5.57 | 0.45 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | -4.23 | -18.06 | 5.92 | -1.13 | NA |
Net Cash From Operating Activities | -12.75 | -16.82 | -15.05 | -7.25 | NA |
Property & Equipment | 0.00 | -0.02 | 0.00 | 0.00 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.81 | 1.00 | 0.00 | NA |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Cash from Investing Activities | 0.00 | 0.79 | 1.00 | 0.00 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 11.40 | 0.00 | 34.89 | 3.70 | NA |
Issuance (Repayment) of Debt | -2.65 | 1.00 | 1.05 | 2.47 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | -0.08 | 0.08 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 2.24 | -2.31 | -2.04 | -0.22 | NA |
Net Cash from Financing Activities | 11.00 | -1.31 | 33.82 | 6.03 | NA |
Effect of Exchange Rate Changes | -0.11 | -0.19 | -0.51 | -0.01 | NA |
Net Change In Cash & Equivalents | -1.86 | -17.53 | 19.26 | -1.22 | NA |
Cash at Beginning of Period | 2.03 | 19.56 | 0.30 | 1.52 | NA |
Cash at End of Period | 0.17 | 2.03 | 19.56 | 0.30 | NA |
Diluted Net EPS | -205.20 | NA | NA | NA | NA |
Fiscal Year End for Allarity Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -11.90 | -10.18 | -5.73 | -3.35 |
Depreciation/Amortization & Depletion | NA | 0.04 | 0.03 | 0.02 | 0.01 |
Net Change from Assets/Liabilities | NA | 3.35 | -0.13 | 1.69 | 0.57 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | -4.23 | -0.80 | -1.67 | -0.43 |
Net Cash From Operating Activities | NA | -12.75 | -11.07 | -5.70 | -3.20 |
Property & Equipment | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 11.40 | 13.12 | 6.32 | 1.16 |
Issuance (Repayment) of Debt | NA | -2.65 | -3.70 | -2.30 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 1.05 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 2.24 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 11.00 | 10.47 | 4.02 | 1.16 |
Effect of Exchange Rate Changes | NA | -0.11 | -0.03 | 0.07 | 0.31 |
Net Change In Cash & Equivalents | NA | -1.86 | -0.63 | -1.61 | -1.73 |
Cash at Beginning of Period | NA | 2.03 | 2.03 | 2.03 | 2.03 |
Cash at End of Period | NA | 0.17 | 1.40 | 0.42 | 0.30 |
Diluted Net EPS | NA | 3,909.20 | -44.80 | -525.60 | -3,544.00 |